Interestingly, we documented retrospectively a second “silent” rise of plasma sC5b-9 concentrations long after the resolution of TTP, without apparent hemolysis and thrombocytopenia and in the absence of anti-CFH autoantibodies (Fig. 1). The gene discussed is CFH; the disease is hemolysis.